Abstract:Background The most common type of kidney cancer that easily metastasizes is clear cell renal cell carcinoma (ccRCC). The expression levels of hyaluronan-mediated motility receptor (HMMR) in many tumor types are significantly enhanced. HMMR is closely associated with tumor-related progression, treatment resistance, and discouraging prognosis, has yet to be fully investigated in terms of its expression patterns and molecular mechanisms of action in ccRCC. Further research is imperative to elucidate these aspects. Methods We used The Cancer Genome Atlas (TCGA) database to preliminarily investigate HMMR expression and function in ccRCC. We assessed the differential expression level of HMMR between ccRCC cancerous tissues and their matched non-tumor tissues. Subsequently, a series of in vivo and in vitro experiments were designed to elucidate the biological function of HMMR in ccRCC, including Transwell migration assays, CCK-8 assays, clone formation assays and subcutaneous xenograft experiments in nude mice. Through bioinformatics analysis, we identified potential microRNAs (miRNAs) that may regulate HMMR, as well as the possible signaling pathways involved. Finally, we conducted a series of cellular functional experiments to validate our hypotheses regarding the HMMR axis. Results HMMR expression was observably up-regulated in tumor tissues of ccRCC patients, and elevated HMMR expression level showed a strong correlation with ccRCC progression and adverse prognoses of patients. Knocking down HMMR inhibited the proliferative and migratory abilities of ccRCC cells, while its overexpression amplified these oncogenic properties. In nude mouse model, reduced HMMR expression inhibited ccRCC tumor proliferation in vivo. Furthermore, overexpression of an upstream transcriptional regulator, miR-9-5p, effectively downregulated HMMR expression and thus impeded ccRCC cells proliferation and migration. In addition, HMMR might influence ccRCC growth via the Epithelial-Mesenchymal Transition (EMT) pathway and the Janus Kinase1/Signal Transducer and Activator of Transcription1 (JAK1/STAT1) pathway. Conclusions HMMR is overexpressed in ccRCC, and there is a significant link between high HMMR expression and tumor progression, as well as poor patient prognosis. Specifically, HMMR could be targeted and inhibited by miR-9-5p and might modulate the tumorigenesis and progression of ccRCC through both EMT and JAK1/STAT1 signaling pathway.

A Comprehensive Investigation Using Meta-Analysis and Bioinformatics on Mir-34A-5p Expression and Its Potential Role in Head and Neck Squamous Cell Carcinoma.

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

Mir-9-5p/hmmr Regulates the Tumorigenesis and Progression of Clear Cell Renal Cell Carcinoma Through EMT and JAK1/STAT1 Signaling Pathway

Bioinformatics Analysis of the Expression and Role of Microrna-221-3p in the Head and Neck Squamous Cell Carcinoma

The Expression and Biological Information Analysis of Mir-375-3p in Head and Neck Squamous Cell Carcinoma Based on 1825 Samples from GEO, TCGA, and Peer-Reviewed Publications.

Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis

Exploring the Role of Mir204/211 in HNSCC by the Combination of Bioinformatic Analysis of Cerna and Transcription Factor Regulation.

Integrated Analysis Of Deregulation Microrna Expression In Head And Neck Squamous Cell Carcinoma

The Comprehensive Landscape of Mir-34A in Cancer Research

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Expression Signature and Role of Mir-30D-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments

The Clinical Value of Mir‐193a‐3p in Non‐small Cell Lung Cancer and Its Potential Molecular Mechanism Explored in Silico Using RNA‐sequencing and Microarray Data

Mir-34A-5p Functions As a Tumor Suppressor in Head and Neck Squamous Cell Cancer Progression by Targeting Flotillin-2.

Diagnostic Significance and Potential Function of Mir-338-5p in Hepatocellular Carcinoma: A Bioinformatics Study with Microarray and RNA Sequencing Data

Down-regulation of Microrna-144-3p and Its Clinical Value in Non-Small Cell Lung Cancer: a Comprehensive Analysis Based on Microarray, Mirna-Sequencing, and Quantitative Real-Time PCR Data

Expression Profile Analysis of Head and Neck Squamous Cell Carcinomas Using Data from the Cancer Genome Atlas

Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets

A Meta-Analysis And Bioinformatics Exploration Of The Diagnostic Value And Molecular Mechanism Of Mir-193a-5p In Lung Cancer

Downregulation of Hsa-Microrna-204-5p and Identification of Its Potential Regulatory Network in Non-Small Cell Lung Cancer: RT-qPCR, Bioinformatic- and Meta-Analyses.

Protective Potential of Mir-146A-5p and Its Underlying Molecular Mechanism in Diverse Cancers: a Comprehensive Meta-Analysis and Bioinformatics Analysis.